Llwytho...
ACS Chemical Neuroscience Molecule Spotlight on Sabril
[Image: see text] Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages 1 month to 2 years and complex partial seizures in adults (tablets).
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Chemical Society
2010
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368665/ https://ncbi.nlm.nih.gov/pubmed/22778839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn100025k |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|